Clinical trial
A Randomized, Double-blind, Two Arm, Controlled Clinical Trial to Compare the Efficacy and Safety of Mycobacterium w (Mw) Administered Along With Standard of Care Versus Placebo Administered Along With Standard of Care, in Adult, COVID 19 Positive Patients Hospitalized But Not Critically Ill.
NCT04358809 is registered in ClinicalTrials.gov with Cadila Pharnmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Two Arm, Controlled Clinical Trial to Compare the Efficacy and Safety of Mycobacterium w (Mw) Administered Along With Standard of Care Versus Placebo Administered Along With Standard of Care, in Adult, COVID 19 Positive Patients Hospitalized But Not Critically Ill.
- Lead sponsor
- Cadila Pharnmaceuticals
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2020
- Completion date
- April 30, 2021
- Enrollment
- 480 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.